Raffaella Casolino: Putting equity at the center of the discussion on innovation in cancer care
Raffaella Casolino, Technical Officer at the World Health Organization, shared a post by Julie Gralow on X, adding:
“Back from incredible few days in Yokohama. Thanks to the organizers for putting equity at the center of the discussion on innovation in cancer care. The only way forward to make meaningful progress.
Thank you ASCO, Japanese Society of Medical Oncology (JSMO) and Japan Society of Clinical Oncology for having me.”
Quoting Julie Gralow’s post:
“ASCOBT24 day 2 kicks off with keynote from Raffaella Casolino, WHO on Building Equity in Cancer Care: From Policy to Action.
‘Health is a right for all, not a privilege for a few’.”
Sources: Raffaella Casolino/X and Julie Gralow/X
Julie Gralow is the Chief Medical Officer (CMO) of the American Society of Clinical Oncology (ASCO). Previously, she was the Jill Bennett Endowed Professor of Breast Cancer at the University of Washington School of Medicine, Professor in the Clinical Research Division of the Fred Hutchinson Cancer Research Center, as well as Director of Breast Medical Oncology at the Seattle Cancer Care Alliance. She is the founder of the Women’s Empowerment Cancer Advocacy Network (WE CAN).
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023